Alterations of activity and intracellular distribution of the 20S proteasome in ageing retinal pigment epithelial cells

Age-related macular degeneration (AMD) remains high incidence and accounts for a main cause of blindness in ageing people, but its mechanism is still poorly understood. Ageing and associated dysfunction of retinal pigment epithelial (RPE) cells were believed to be the pathological onset of AMD. 20S proteasome has been tightly correlated with cell ageing due to its fundamental role in maintaining cellular homeostasis, but its implication in the ageing process of human RPE cells was seldom concerned. This study aimed to demonstrate the interconnections between 20S proteasome and ageing RPE cells by characterizing age-dependent alterations of the 20S proteasome in primarily cultured human RPE cells. For this purpose, a replicative ageing RPE cell model was established and validated through testing the cell viability, beta-galactosidase activity and cellular autofluorescence. Decline in chymotrypsin-like, peptidylglutamyl-peptide hydrolase and trypsin-like activities of the 20S proteasome was detected in aged RPE cells through degradation of fluorogenic substrates. Immunofluorescence assay revealed that the 20S proteasome was concentrated in RPE nucleus, and redistributed partly to the peri-nuclear regions in old RPE passages. These age-dependent changes of the 20S complex were accompanied with a significantly increased fluorescent intensity of intracellular oxidized proteins. Further analysis of the proteasome-to-oxidized protein ratio indicated a preferred protection of the RPE nuclear proteins by the 20S proteasome, which also subsided remarkably as a function of the cell ageing. In conclusion, we demonstrated functional impairment and redistribution of the 20S proteasome with age in human RPE cells and supposed these alterations impactful on the process of RPE cell ageing and furthermore on the pathogenesis of AMD. Future researches on the mechanism of these alterations and the pathways to manipulate their effects are still strongly recommended.

[1]  K. Davies,et al.  Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. , 2005, Free radical biology & medicine.

[2]  M. Ivan,et al.  Proteasome-dependent regulation of signal transduction in retinal pigment epithelial cells. , 2006, Experimental eye research.

[3]  P. Radziwon,et al.  Human platelet 20S proteasome: inhibition of its chymotrypsin-like activity and identification of the proteasome activator PA28. A preliminary report , 2003, Platelets.

[4]  Bertrand Friguet,et al.  Impact of ageing on proteasome structure and function in human lymphocytes. , 2003, The international journal of biochemistry & cell biology.

[5]  B. McKay,et al.  In vitro aging of bovine and human retinal pigment epithelium: number and activity of the Na/K ATPase pump. , 1993, Experimental eye research.

[6]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[7]  D. Ferrington,et al.  Age-dependent inhibition of proteasome chymotrypsin-like activity in the retina. , 2007, Experimental eye research.

[8]  K Tanaka,et al.  Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.

[9]  Marco A Zarbin,et al.  Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[10]  N. Chondrogianni,et al.  Overexpression of Proteasome β5 Assembled Subunit Increases the Amount of Proteasome and Confers Ameliorated Response to Oxidative Stress and Higher Survival Rates*[boxs] , 2005, Journal of Biological Chemistry.

[11]  Moonhee Lee,et al.  Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins , 2003, Journal of neurochemistry.

[12]  Tobias Jung,et al.  Oxidized proteins: intracellular distribution and recognition by the proteasome. , 2007, Archives of biochemistry and biophysics.

[13]  J. Kleinschmidt,et al.  Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. , 1994, The Journal of biological chemistry.

[14]  N. Chondrogianni,et al.  Protein degradation during aging: The lysosome-, the calpain- and the proteasome-dependent cellular proteolytic systems , 2004, Biogerontology.

[15]  C. Franceschi,et al.  Fibroblast cultures from healthy centenarians have an active proteasome , 2000, Experimental Gerontology.

[16]  E. Hol,et al.  Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression , 2003, Journal of neurochemistry.

[17]  B. Friguet,et al.  Proteasome function in aging and oxidative stress: implications in protein maintenance failure. , 2006, Antioxidants & redox signaling.

[18]  B. Friguet,et al.  Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes. , 2002, Free radical biology & medicine.

[19]  T. Grune,et al.  The nuclear proteasome and the degradation of oxidatively damaged proteins , 2006, Amino Acids.

[20]  M. Figueiredo-Pereira,et al.  Aging and regulated protein degradation: who has the UPPer hand? , 2007, Aging cell.

[21]  C. Nordgaard,et al.  Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. , 2007, American journal of ophthalmology.

[22]  H. Ovaa,et al.  Lower expression of catalytic and structural subunits of the proteasome contributes to decreased proteolysis in peripheral blood T lymphocytes during aging. , 2007, The international journal of biochemistry & cell biology.

[23]  K. Davies,et al.  Ubiquitin Conjugation Is Not Required for the Degradation of Oxidized Proteins by Proteasome* , 2003, The Journal of Biological Chemistry.

[24]  A. Mazur,et al.  Low-magnesium induces senescent features in cultured human endothelial cells. , 2007, Magnesium research.

[25]  V. Pérez,et al.  Proteasome modulates mitochondrial function during cellular senescence. , 2008, Free radical biology & medicine.

[26]  B. Friguet,et al.  Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts , 2003, Journal of Biological Chemistry.

[27]  B. Friguet,et al.  Age-dependent protein modifications and declining proteasome activity in the human lens. , 2004, Archives of biochemistry and biophysics.

[28]  Jae Sung Hwang,et al.  Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[29]  A. Ciechanover,et al.  Narrative Review: Protein Degradation and Human Diseases: The Ubiquitin Connection , 2006, Annals of Internal Medicine.

[30]  N. Chondrogianni,et al.  Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures , 2004, Biogerontology.

[31]  Y. Hui,et al.  Migration of retinal pigment epithelial cells in vitro modulated by monocyte chemotactic protein-1: enhancement and inhibition , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  N. Chondrogianni,et al.  The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts. , 2007, Rejuvenation research.

[33]  L. Szweda,et al.  Aging, lipofuscin formation, and free radical-mediated inhibition of cellular proteolytic systems , 2003, Ageing Research Reviews.

[34]  Tobias Jung,et al.  Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress. , 2006, Free radical biology & medicine.

[35]  D. Ferrington,et al.  Altered proteasome structure, function, and oxidation in aged muscle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  A. Keshavarzian,et al.  Determination of protein carbonyl groups by immunoblotting. , 1999, Analytical biochemistry.

[37]  J. Burke.  Cytochrome oxidase activity in bovine and human retinal pigment epithelium: topographical and age-related differences. , 1993, Current eye research.

[38]  N. Breusing,et al.  Regulation of proteasome-mediated protein degradation during oxidative stress and aging , 2008, Biological chemistry.

[39]  N. Chondrogianni,et al.  Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence , 2007, Experimental Gerontology.

[40]  Ø. Bruserud,et al.  The proteasome inhibitors bortezomib and PR‐171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells , 2007, British journal of haematology.

[41]  Yizhi Liu,et al.  Cytoprotective effects of proteasome β5 subunit overexpression in lens epithelial cells , 2007, Molecular vision.

[42]  B. Friguet,et al.  Protein Degradation by the Proteasome and Its Implications in Aging , 2000, Annals of the New York Academy of Sciences.

[43]  J. Burke,et al.  Autofluorescent inclusions in long-term postconfluent cultures of retinal pigment epithelium. , 1998, Investigative ophthalmology & visual science.

[44]  J. Trowsdale,et al.  Dynamics of proteasome distribution in living cells , 1997, The EMBO journal.

[45]  K. Davies.  Degradation of oxidized proteins by the 20S proteasome. , 2001, Biochimie.

[46]  B. Wagner,et al.  Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification. , 2006, Investigative ophthalmology & visual science.

[47]  T. Zglinicki,et al.  Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. , 2000, Free radical biology & medicine.

[48]  M. Boulton,et al.  Ageing of the retinal pigment epithelium: implications for transplantation , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[49]  N. Chondrogianni,et al.  Proteasome dysfunction in mammalian aging: Steps and factors involved , 2005, Experimental Gerontology.

[50]  B. Friguet,et al.  Inhibition of the multicatalytic proteinase (proteasome) by 4‐hydroxy‐2‐nonenal cross‐linked protein , 1997, FEBS letters.

[51]  P. Campochiaro,et al.  Oxidative damage in age-related macular degeneration. , 2007, Histology and histopathology.

[52]  K. Davies,et al.  Protein oxidation and degradation during postmitotic senescence. , 2005, Free radical biology & medicine.

[53]  M. Boulton,et al.  The role of the retinal pigment epithelium: Topographical variation and ageing changes , 2001, Eye.

[54]  A. Konstas,et al.  High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein. , 2005, Free radical biology & medicine.

[55]  A. Mishra,et al.  Aspirin Induces Apoptosis through the Inhibition of Proteasome Function* , 2006, Journal of Biological Chemistry.

[56]  J. Louie,et al.  Proteasome function and protein oxidation in the aged retina. , 2002, Experimental eye research.

[57]  B. Friguet,et al.  Age-related alterations of proteasome structure and function in aging epidermis , 2000, Experimental Gerontology.

[58]  A. Rivett,et al.  Catalytic Properties of 26 S and 20 S Proteasomes and Radiolabeling of MB1, LMP7, and C7 Subunits Associated with Trypsin-like and Chymotrypsin-like Activities* , 1997, The Journal of Biological Chemistry.